News Announcement

Concord Biotech: Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2024

Pursuant to Regulation 30 and 33 of the SEBI(LODR) regulations 2015 as amended from time to time we enclosed herewith the unaudited standalone and consolidated financial statement for the second quarter and half year ended September 2024 along with the limited review report with unmodified opinion issued by M/s. BSR & co. LLP the statutory auditors.


दूसरी कैटेगरी